Additionally, elevated ZNF90 expression was associated with reduced overall survival in GC patients (Fig. 6F) and exhibited upregulation in GC tissues and cells relative to controls (Fig. 6G–H). The gene discussed is ZNF90; the disease is gastric cancer.